Ofer Toledano

Company: Sol Gel Technologies

Job title: Vice President - Research & Development

Seminars:

Advancing Topical Therapies for Rare Dermatologic Diseases for Safer, More Targeted Treatment 1:30 pm

Enabling topical delivery of novel molecules, aiming to reduce systemic exposure and adverse events in rare skin conditions Understanding the different regulatory and funding approaches required for the rare space SGT-610, currently in Phase 3 for Gorlin Syndrome, offers an alternative to systemic hedgehog inhibitors with a potentially improved safety profile SGT-210, in Phase 1…Read more

day: Day Two PM